Author

Brigid V. Troan

North Carolina State UniversityORCID 0000-0003-2212-2167Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:multiple species· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrianus C. M. BooniD· 1 shared Amy M. BoddyiD· 1 shared Carlo C. MaleyiD· 1 shared Elizabeth G. DukeiD· 1 shared Ethan J. FritchiD· 1 shared James W. JanetkaiD· 1 shared Joshua David SchiffmaniD· 1 shared Kendra L. GullyiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adrianus C. M. BoonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evolutionary BiologybioRxivPreprintDec 11, 2025

Immune-cancer analyses across mammals reveal a potential trophic level and platelet-linked tradeoff between cancer and trauma mortality

Stefania E. Kapsetaki, Sareh Seyedi, Zachary Taylor Compton…·Amy M. Boddy

The paper analyzes immune-cancer tradeoffs across mammals, finding a negative correlation between cancer and trauma mortality, mediated by platelet size and trophic level.

1 citation

multiple speciesstatistical model

𝕏 PostBluesky

MicrobiologyJournal of VirologyPeer-reviewedApr 9, 2024

Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19

Adrianus C. M. Boon, Traci L. Bricker, Ethan J. Fritch…·James W. Janetka

This paper demonstrates that MM3122, a host cell serine protease inhibitor, effectively inhibits SARS-CoV-2 replication and reduces disease severity in mice, both prophylactically and therapeutically.

19 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky